Ibuprofen and Oxcarbazepine Tablets Recalled Over Mislabeled Packaging

Mislabeled packaging could lead to patients receiving ibuprofen tablets instead of oxcarbazepine intended for treating seizures in patients with epilepsy. American Health Packaging (AHP) has issued a voluntary recall on Ibuprofen and Oxcarbazepine tablets that may have been mislabeled.

Learn more about the recall from the U.S. Food and Drug Administration’s website.